Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Sony Djibouti Intermediate
Sony Gibbs (Inn), Also Known As Lde225, Marketed As Odomzo, Is A Hedgehog Signaling Pathway Inhibitor (Through Smooth Antagonism), And Novartis Is Developing It As An Anticancer Agent.
4-Trifluoromethoxyphenylboronic acid
UP774133182139301-27-2
cis-2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine
UP532979726956699-05-1